FELIGEN CRP/R
FELIGEN CRP/R
Authorised
- Feline panleucopenia virus, strain LR 72, Live
- Felid herpesvirus 1, strain F2, Live
- Feline calicivirus, strain F9, Live
- Rabies virus, strain VP12, Inactivated
Product identification
Medicine name:
FELIGEN CRP/R
Active substance:
- Feline panleucopenia virus, strain LR 72, Live
- Felid herpesvirus 1, strain F2, Live
- Feline calicivirus, strain F9, Live
- Rabies virus, strain VP12, Inactivated
Target species:
-
Cat
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Feline panleucopenia virus, strain LR 72, Live3.00/log10 50% cell culture infectious dose1.00Dose
-
Felid herpesvirus 1, strain F2, Live5.00/log10 50% cell culture infectious dose1.00Dose
-
Feline calicivirus, strain F9, Live4.10/log10 50% cell culture infectious dose1.00Dose
-
Rabies virus, strain VP12, Inactivated1.00/international unit(s)1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cat
-
Unspecified0day
-
-
-
Subcutaneous use
-
Cat
-
Unspecified0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI06AH
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet